BACKGROUND: Resuscitation research requires an exception from informed consent (EFIC). Despite concerns that patients may find EFIC unacceptable, the views and experiences of patients enrolled in an EFIC study are largely unknown. METHODS: The Patients' Experience in Emergency Research (PEER) study was nested within the Rapid Anticonvulsant Medication Prior to Arrival Trial (RAMPART) for pre-hospital treatment of status epilepticus. PEER included 61 EFIC enrollees or their surrogates from 5 sites. Interviews used a structured, interactive guide focusing on acceptance of EFIC enrollment in RAMPART and existing regulatory protections. Simple statistics were generated, and textual data were analyzed for common themes. RESULTS: 24 enrolled patients and 37 surrogates were successfully interviewed. 49/60 (82%) were glad they or their family member were included in RAMPART; 54/57 (95%) felt research on emergency seizure treatment is important. 43/59 (73%) found their inclusion under EFIC acceptable; 10 (17%) found it unacceptable, and 6 (10%) were neutral. There were no statistically significant interactions between enrollment attitudes and demographic characteristics, though there were trends toward lower acceptance among interviewees who were non-white, less educated, or had prior research experience. The most common concerns related to lack of consent prior to RAMPART enrollment. Positive responses related to perceived medical benefits, recognition of the impracticality of consent, and wanting doctors to do what needs to be done in emergencies. Many participants had difficulty understanding the trial and EFIC. CONCLUSIONS: Most subjects had positive views of enrollment, and acceptance generally correlated with results of community consultation studies.
BACKGROUND: Resuscitation research requires an exception from informed consent (EFIC). Despite concerns that patients may find EFIC unacceptable, the views and experiences of patients enrolled in an EFIC study are largely unknown. METHODS: The Patients' Experience in Emergency Research (PEER) study was nested within the Rapid Anticonvulsant Medication Prior to Arrival Trial (RAMPART) for pre-hospital treatment of status epilepticus. PEER included 61 EFIC enrollees or their surrogates from 5 sites. Interviews used a structured, interactive guide focusing on acceptance of EFIC enrollment in RAMPART and existing regulatory protections. Simple statistics were generated, and textual data were analyzed for common themes. RESULTS: 24 enrolled patients and 37 surrogates were successfully interviewed. 49/60 (82%) were glad they or their family member were included in RAMPART; 54/57 (95%) felt research on emergency seizure treatment is important. 43/59 (73%) found their inclusion under EFIC acceptable; 10 (17%) found it unacceptable, and 6 (10%) were neutral. There were no statistically significant interactions between enrollment attitudes and demographic characteristics, though there were trends toward lower acceptance among interviewees who were non-white, less educated, or had prior research experience. The most common concerns related to lack of consent prior to RAMPART enrollment. Positive responses related to perceived medical benefits, recognition of the impracticality of consent, and wanting doctors to do what needs to be done in emergencies. Many participants had difficulty understanding the trial and EFIC. CONCLUSIONS: Most subjects had positive views of enrollment, and acceptance generally correlated with results of community consultation studies.
Authors: Scott E Kasner; Jill M Baren; Peter D Le Roux; Pamela G Nathanson; Katherine Lamond; Stacy L Rosenberg; Jason Karlawish Journal: Ann Emerg Med Date: 2010-09-27 Impact factor: 5.721
Authors: Katie B McClure; Nicole M DeIorio; Mary D Gunnels; Maria J Ochsner; Michelle H Biros; Terri A Schmidt Journal: Acad Emerg Med Date: 2003-04 Impact factor: 3.451
Authors: Charles Contant; Laurence B McCullough; Lorna Mangus; Claudia Robertson; Alex Valadka; Baruch Brody Journal: Crit Care Med Date: 2006-08 Impact factor: 7.598
Authors: Robert Silbergleit; Valerie Durkalski; Daniel Lowenstein; Robin Conwit; Arthur Pancioli; Yuko Palesch; William Barsan Journal: N Engl J Med Date: 2012-02-16 Impact factor: 91.245
Authors: Eileen M Bulger; Terri A Schmidt; Andrea J Cook; Karen J Brasel; Denise E Griffiths; Peter J Kudenchuk; Daniel Davis; Berit Bardarson; Ahamed H Idris; Tom P Aufderheide Journal: Ann Emerg Med Date: 2008-09-27 Impact factor: 5.721
Authors: Jestin N Carlson; Dana Zive; Denise Griffiths; Karen N Brown; Robert H Schmicker; Heather Herren; George Sopko; Sara DiFiore; Dixie Climer; Caroline Herdeman; Ahamed Idris; Graham Nichol; Henry E Wang Journal: Resuscitation Date: 2018-12-17 Impact factor: 5.262
Authors: Louisa W Whitesides; Jill M Baren; Michelle H Biros; Ross J Fleischman; Prasanthi R Govindarajan; Elizabeth B Jones; Arthur M Pancioli; Rebecca D Pentz; Victoria M Scicluna; David W Wright; Neal W Dickert Journal: Clin Trials Date: 2016-11-15 Impact factor: 2.486
Authors: Neal W Dickert; Victoria M Scicluna; Jill M Baren; Michelle H Biros; Ross J Fleischman; Prasanthi R Govindarajan; Elizabeth B Jones; Arthur M Pancioli; David W Wright; Rebecca D Pentz Journal: Crit Care Med Date: 2015-03 Impact factor: 7.598
Authors: Neal W Dickert; Victoria A Mah; Michelle H Biros; Deneil M Harney; Robert Silbergleit; Jeremy Sugarman; Emir Veledar; Kevin P Weinfurt; David W Wright; Rebecca D Pentz Journal: Crit Care Med Date: 2014-02 Impact factor: 7.598
Authors: Neal W Dickert; Kathleen Metz; Michael D Fetters; Adrianne N Haggins; Deneil K Harney; Candace D Speight; Robert Silbergleit Journal: Acad Emerg Med Date: 2021-05-26 Impact factor: 5.221
Authors: Nina H Gobat; Micaela Gal; Nick A Francis; Kerenza Hood; Angela Watkins; Jill Turner; Ronald Moore; Steve A R Webb; Christopher C Butler; Alistair Nichol Journal: Trials Date: 2015-12-29 Impact factor: 2.279
Authors: Jeremy Furyk; Kristin McBain-Rigg; Kerrianne Watt; Theophilus I Emeto; Richard C Franklin; Donna Franklin; Andreas Schibler; Stuart R Dalziel; Franz E Babl; Catherine Wilson; Natalie Phillips; Robin Ray Journal: BMJ Open Date: 2017-11-15 Impact factor: 2.692
Authors: Seth W Linakis; Nathan Kuppermann; Rachel M Stanley; Hilary Hewes; Sage Myers; John M VanBuren; T Charles Casper; Matthew Bobinski; Simona Ghetti; Walton O Schalick; Daniel K Nishijima Journal: Acad Emerg Med Date: 2021-08-06 Impact factor: 3.451